MarketPeel
Insider Trading Intelligence
Pricing
…
EC

Elizabeth Crowley

CLDX
SR. VP &CPDO · CELLDEX THERAPEUTICS, INC. · CIK 0001681854
FILING MIX · LIFETIME50%/50%
BUYS
14
SELLS
14
TOTAL VALUE
$3.91M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
100,000
AVG SELL PX
$35.00
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Elizabeth Crowley, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+28.57%+1.49%+1.52%-0.03%+1.13%—
14d7+57.14%+1.29%+1.64%-0.34%-2.32%—
30d7+57.14%-5.03%+0.85%-5.88%-7.60%—
60d7+85.71%-6.03%+1.32%-7.35%-15.97%—
90d7+57.14%-8.42%-0.41%-8.01%-16.96%—
180d7+100.00%-28.54%+0.22%-28.76%-28.76%—
1y7+100.00%-25.87%-2.94%-22.94%-4.67%—
2y7+100.00%-27.84%+10.30%-41.83%-41.28%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CLDX · 100,000 shares · as of Jun 25, 2026
025,00050,00075,000100,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 14 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Jun 25, 2026Jun 29, 2026 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,000——85,000Jun 5, 2025Jun 9, 2025 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
30,000——46,500Jun 14, 2024Jun 18, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CPDO
30,000$10.38$311.4K39,074Jun 14, 2024Jun 18, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
30,000$34.87$1.05M9,074Jun 14, 2024Jun 18, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,000——85,000Jun 13, 2024Jun 17, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
15,000$35.06$525.9K9,074Jun 7, 2024Jun 11, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
7,500——0Jun 7, 2024Jun 11, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CPDO
7,500$9.02$67.6K24,074Jun 7, 2024Jun 11, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
7,500——76,500Jun 7, 2024Jun 11, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CPDO
7,500$10.38$77.8K16,574Jun 7, 2024Jun 11, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CPDO
34,445$2.78$95.8K39,171May 30, 2024Jun 3, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
SR. VP & CPDO
8,500$9.02$76.6K47,671May 30, 2024Jun 3, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
8,500——7,500May 30, 2024Jun 3, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
38,597$33.64$1.30M9,074May 30, 2024Jun 3, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
SR. VP & CPDO
34,445——0May 30, 2024Jun 3, 2024 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Jun 15, 2023Jun 20, 2023 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
77,000——77,000Jun 16, 2022Jun 17, 2022 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP &CPDO
4,000$40.00$160.0K4,726Dec 8, 2021Dec 10, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP &CPDO
4,000——16,000Dec 8, 2021Dec 10, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
Sr. VP &CPDO
4,000$9.02$36.1K8,726Dec 8, 2021Dec 10, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP &CPDO
2,528$44.12$111.5K6,515Nov 1, 2021Nov 3, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASE
Sr. VP &CPDO
8,555$2.78$23.8K9,043Nov 1, 2021Nov 3, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP &CPDO
1,189$41.62$49.5K4,726Nov 1, 2021Nov 3, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP &CPDO
8,555——34,445Nov 1, 2021Nov 3, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
SALE
Sr. VP &CPDO
600$43.11$25.9K5,915Nov 1, 2021Nov 3, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
58,000——58,000Jun 17, 2021Jun 21, 2021 ↗View →
CLDX
CELLDEX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
84,000——84,000Jun 18, 2020Jun 19, 2020 ↗View →
Other insiders · CLDX
Loading peer insiders…
About this filer
CIK 0001681854
ROLE
SR. VP &CPDO
PRIMARY
CLDX
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001681854DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback